Publicaciones en las que colabora con Manuel Macías González (9)

2015

  1. Novel Oxazolidinone-Based Peroxisome Proliferator Activated Receptor Agonists: Molecular Modeling, Synthesis, and Biological Evaluation

    Journal of Medicinal Chemistry, Vol. 58, Núm. 16, pp. 6639-6652

2014

  1. Computational and biological evaluation of n-octadecyl- n9-propylsulfamide, a selective ppara agonist structurally related to n-acylethanolamines

    PLoS ONE, Vol. 9, Núm. 3

2012

  1. Anti-obesity efficacy of LH-21, a cannabinoid CB 1 receptor antagonist with poor brain penetration, in diet-induced obese rats

    British Journal of Pharmacology, Vol. 165, Núm. 7, pp. 2274-2291

  2. Elaidyl-sulfamide, an oleoylethanolamide-modelled PPARα agonist, reduces body weight gain and plasma cholesterol in rats

    DMM Disease Models and Mechanisms, Vol. 5, Núm. 5, pp. 660-670

  3. Unsaturated fatty alcohol derivatives of olive oil phenolic compounds with potential low-density lipoprotein (LDL) antioxidant and antiobesity properties

    Journal of Agricultural and Food Chemistry, Vol. 60, Núm. 4, pp. 1067-1074

2011

  1. Discovery of potent dual PPARα agonists/CB1 ligands

    ACS Medicinal Chemistry Letters, Vol. 2, Núm. 11, pp. 793-797

2010

  1. Synthesis of fatty acid amides of catechol metabolites that exhibit antiobesity properties

    ChemMedChem, Vol. 5, Núm. 10, pp. 1781-1787

2008

  1. Antiobesity designed multiple ligands: Synthesis of pyrazole fatty acid amides and evaluation as hypophagic agents

    Bioorganic and Medicinal Chemistry, Vol. 16, Núm. 23, pp. 10098-10105

2007

  1. Novel sulfamide analogs of oleoylethanolamide showing in vivo satiety inducing actions and PPARα activation

    Journal of Medicinal Chemistry, Vol. 50, Núm. 2, pp. 389-393